CT can outperform fluoro-based enteroclysis, the current imaging standard for small bowel evaluation in patients with Crohn's disease, according to a study in the American Journal of Roentgenology.
CT can outperform fluoro-based enteroclysis, the current imaging standard for small bowel evaluation in patients with Crohn's disease, according to a study in the American Journal of Roentgenology.
The big advantage of CT enteroclysis is its ability to detect complications that exist outside normal parameters of the diagnosis and identification of Crohn's disease, according to principal investigator Dr. Johannes Sailer, a radiologist at the Medical University of Vienna.
Researchers evaluated with both techniques 50 symptomatic patients. Results were matched with surgery and follow-up (AJR 2005;185;1575-1581). CT enteroclysis proved better than conventional enteroclysis at detecting fistulae, abscesses, and conglomeration of small bowel loops. CT enteroclysis also proved equivalent to standard imaging in the detection of minimal mucosal changes.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.